NicOx Blood Pressure Data Positive, But Is it Enough?

Shares in France's largest biotech, NicOx, received a small boost Dec. 17 after the company reported positive blood pressure data for Phase III-hopeful naproxcinod

More from Archive

More from Pink Sheet